跳至主要内容
临床试验/IRCT20200721048159N4
IRCT20200721048159N4招募中3 期

Comparison of Effectiveness of Remdesivir with Remdesivir and Interferon Beta-1 a Treatment Regime on Clinical Outcome of Covid 19 Patients

Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Hospitalized patients suspected to Covid19 infection
  • SpO2 less than 93%
  • The presence of respiratory symptoms (including shortness of breath, pain and pressure in the chest)
  • older than 40 years

排除标准

  • Dissatisfaction with participating in the study
  • History of severe renal failure
  • History of allergies to interferon or remdesivir
  • History of severe liver failure

研究者

发起方
Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences

相似试验